Ebaresdax
Ebaresdax (ACP-044) can inhibit peroxynitrite oxidation derived by SIN-1 and peroxynitrite mediated Cytotoxicity with IC50s of 3.7±0.80 and 0.13±0.02 uM, respectively[1].
Product Specifications
CAS Number
1334471-39-4
Product Name Alternative
ACP-044
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/ebaresdax.html
Purity
99.85
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
OC([C@H](C(C)(S1)C)N=C1NC2=C(C=CC=C2)O)=O
Molecular Formula
C12H14N2O3S
Molecular Weight
266.32
References & Citations
[1]Mannion, James C.; Dax, Scott L. Analgesic compounds, compositions, and uses thereof. WO2011112602A1
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-B310515-250MG 250 mg
tert-Butyl 6-Amino-3,4-dihydroquinoline-1(2H)-carboxylate
Sign In for Pricing
View Details 
BNC880385-500 1x 500 µL
CD3e (Rabbit PAb), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
